In this context, it was hypothesized that the significant changes in the lipidprofile are related to polymorphisms of the ApoB gene (rs1042031and rs693), and the improvement of the aerobic functional capacity is associatedwith the ACE I-allele in patients with CAD and/or cardiovascularrisk factors submitted to the AIT program. This evidence concerns the gene APOB and coronary artery disorder.